Antithymocyte Globulin: Clinical Trials

51 trials of Antithymocyte Globulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 11 terminated, 4 withdrawn, 3 unknown. 51 Phase 2, 6 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 251Completed 29, Terminated 11, Withdrawn 4, Unknown 3, Active not recruiting 2, Recruiting 2
Phase 16Completed 3, Terminated 2, Active not recruiting 1
Phase 33Completed 2, Terminated 1

Follow Antithymocyte Globulin: new trials by email Literature Review of Antithymocyte Globulin trials Research Report on Antithymocyte Globulin

Trials (filtered) newest first · largest first

All 51 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of TCD601 in de Novo Renal Transplant Recipients
TCD601, belatacept, ATG - Renal Transplantation
Phase 2CompletedITB-Med LLC762023-12-282026-05-05
STOP-T1D Low-Dose (ATG)
Antithymocyte Globulin, Placebo (for ATG) - Diabetes Mellitus, Type 1
Phase 2TerminatedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)22023-11-012026-05-07
Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy
Romiplostim, Antithymocyte Globulin, Cyclosporine A - Severe Aplastic Anemia (SAA)
Phase 2WithdrawnAmgen2023-08-312023-09-29
Selective CD28 Blockade in Renal Transplant Recipients
Lulizumab, Tacrolimus, Thymoglobulin® - Kidney Transplantation, Renal Transplant Recipients
Phase 2WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2022-01-102023-03-22
Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Anti-Thymocyte Globulin, Busulfan, Cyclophosphamide - Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 2WithdrawnFred Hutchinson Cancer Center2021-06-012021-06-30
Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
Antithymocyte Globulin - Haploidentical Hematopoietic Stem Cell Transplantation
Phase 2UnknownChinese PLA General Hospital632020-12-012023-04-11
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
Anti-Thymocyte Globulin, Cyclophosphamide, Cytokine-treated Veto Cells - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1 / Phase 2Active not recruitingM.D. Anderson Cancer Center162019-08-082026-06-11
RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT
Cytarabine - Acute Leukemia, Myelodysplastic Syndromes
Phase 2UnknownPeking University People's Hospital502018-02-012024-03-26
RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT
Cytarabine - Myelodysplastic Syndromes
Phase 2UnknownPeking University People's Hospital502018-02-012022-04-20
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
Anti-Thymocyte Globulin, Busulfan, Clofarabine - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 2CompletedM.D. Anderson Cancer Center62017-10-132023-10-11
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin - Kidney Transplant, Type 1 Diabetes
Phase 2CompletedMassachusetts General Hospital22017-01-012023-12-22
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
Thymoglobulin, Bortezomib, Tacrolimus - Acute Leukemia, Chronic Lymphocytic Leukemia
Phase 2TerminatedEmory University52016-09-012018-04-30
Personalized NK Cell Therapy in CBT
Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 2RecruitingM.D. Anderson Cancer Center1002016-05-192026-11-02
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
living related donor partial liver transplantation, Total body irradiation, Bone marrow transplant from same donor - Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant)
Phase 2WithdrawnSidney Kimmel Comprehensive Cancer Center at Johns Hopkins2016-03-012018-06-15
CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma
Anti-Thymocyte Globulin, Cyclosporine, Mycophenolate Mofetil - Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma
Phase 2CompletedRobert Lowsky182015-06-012021-06-24
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging - Leukemia, Lymphoma
Phase 2CompletedM.D. Anderson Cancer Center202013-01-012020-05-05
Allogeneic Stem Cell Transplant for CLL
Allogeneic Hematopoietic Stem Cell Transplantation, Anti-Thymocyte Globulin, Busulfan - Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Chronic Lymphocytic Leukemia
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center152012-11-212020-02-24
CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
Allogeneic Bone Marrow Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation, Anti-Thymocyte Globulin - Hematopoietic and Lymphoid Cell Neoplasm
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center272012-10-292024-07-23
Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Allogeneic Bone Marrow Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation, Anti-Thymocyte Globulin - Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center642012-10-252025-02-28
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
Anti-Thymocyte Globulin, Cyclosporine, Filgrastim - Aplastic Anemia, de Novo Myelodysplastic Syndrome
Phase 2RecruitingM.D. Anderson Cancer Center1402012-06-252026-06-22

Showing 20 of 51. Sign in to see all of them.

Conditions studied

Myelodysplastic Syndromes (16)  ·  Leukemia, Myeloid, Acute (9)  ·  Hodgkin Disease (8)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (7)  ·  Anemia, Aplastic (6)  ·  Diabetes Mellitus, Type 1 (6)  ·  Graft vs Host Disease (6)  ·  Leukemia (6)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (6)  ·  Lymphoma, Non-Hodgkin (6)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (6)  ·  Hematologic Neoplasms (5)  ·  Lymphoma (5)  ·  Anemia, Refractory, with Excess of Blasts (4)  ·  Myeloproliferative Disorders (4)

Sponsors

M.D. Anderson Cancer Center (20)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Fred Hutchinson Cancer Center (4)  ·  Masonic Cancer Center, University of Minnesota (3)  ·  Massachusetts General Hospital (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  Peking University People's Hospital (2)  ·  Amgen (1)  ·  Children's Oncology Group (1)  ·  Chinese PLA General Hospital (1)  ·  Emory University (1)  ·  ITB-Med LLC (1)  ·  National Cancer Institute (NCI) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  National Institutes of Health Clinical Center (CC) (1)

Countries

United States (47)  ·  China (3)  ·  Australia (1)  ·  Canada (1)

Top investigators

Issa Khouri (2)  ·  Leona Holmberg (2)  ·  Xiao-Jun Huang (2)  ·  Ali Naji, MD, PhD (1)  ·  Amanda Olson (1)  ·  Amin Alousi, MD (1)  ·  Amin M. Alousi, MD (1)  ·  Andrew B. Adams, MD, PhD (1)  ·  Andrew Posselt, MD, PhD (1)  ·  Angela Smith, MD (1)  ·  Bernhard Hering, MD (1)  ·  Camillo Ricordi, MD (1)  ·  Chitra Hosing (1)  ·  Chitra M. Hosing, MD (1)  ·  Christian P. Larsen, MD, DPhil (1)

Results publications

PMID 20107229, PMID 20383216, PMID 20946966, PMID 23901089, PMID 24622416, PMID 26416896, PMID 27053235, PMID 27208317, PMID 28198767, PMID 31212080, PMID 33718234, PMID 37706580, PMID 39348419, PMID 39624016, PMID 39949947, PMID 40443407

NIH funding

P30CA015704 (2), P30CA016672 (2), P01CA049605 (1), R01CA211044 (1), U01AI138909 (1), U10CA031946 (1), U10CA180821 (1), UC4DK117009-01 (1)